October 20, 2014 |
Why the First Closed Loop Artificial Pancreas Did Not Come From a Medical School
September 15, 2014  | 

Santa Barbara, CA - Recently, Medical-Horizons.net had the opportunity to sit down with Dr. Scott Hammond of the University of California Santa Barbara's Translational Medical Research Laboratories.

M-H.Net: Dr. Hammond, thank you for taking to time to speak with us today.  We’re excited to have this opportunity to learn about your approach to translational medicine at TMRL.  We’re accustomed to seeing breakthrough research associated with medical schools, but you’re doing something a little different here. Can you explain?

Dr. Hammond: As Executive Director of the UCSB Translational Medical Research Laboratories I’m frequently heard saying “no medical school, no problem.”  At the TMRL we’re redefining biomedical research by applying a “systems approach” to medical research and partnering with researchers and clinicians from around the world to develop solutions and expedite the application of medical research.  The interconnectivity that links the world and a collaborative research climate, coupled with a top 10 College of Engineering, are assets that are efficient and effective at creating strategies for addressing complex medical problems. 

For example, UCSB researchers have developed an artificial pancreas with the only closed loop, insulin regulation system in the world for patients with T1 Diabetes.  It is currently in out-patient, multi-center clinical trials around the world. Continue>

Page | 1 2 3 4 5 6 7
Suggested Articles